132 related articles for article (PubMed ID: 18332606)
21. Hepatocellular carcinoma with gastric metastasis treated by simultaneous hepatic and gastric resection: report of a case.
Haruki K; Misawa T; Gocho T; Saito R; Shiba H; Akiba T; Yanaga K
Clin J Gastroenterol; 2016 Oct; 9(5):319-23. PubMed ID: 27484064
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma with metastatic gastric cancer simulating Borrmann type 2 and hyperlipidemia.
Makino H; Takazakura E; Nakamura S; Kobayashi K; Hattori N; Nonomura A; Ohta G
Acta Pathol Jpn; 1986 Apr; 36(4):577-86. PubMed ID: 3014813
[TBL] [Abstract][Full Text] [Related]
23. Liver cell adenoma in a young man with elevated serum PIVKA-II level.
Uto H; Shigehira M; Kawano T; Nagatomo H; Kuribayashi T; Taniguchi S; Koga K; Komada N; Kitamura T; Maruyama T; Tsubouchi H
J Gastroenterol; 1996 Jun; 31(3):441-5. PubMed ID: 8726839
[TBL] [Abstract][Full Text] [Related]
24. [Gastric metastasis of hepatocellular carcinoma treated by transarterial chemoembolization: a case report].
Kim JH; Park JW; Choi JI; Kim HB; Koh DW; Lee WJ; Kim CM
Korean J Hepatol; 2007 Mar; 13(1):91-5. PubMed ID: 17380079
[TBL] [Abstract][Full Text] [Related]
25. A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
Oshiro Y; Takada Y; Enomoto T; Fukao K; Ishikawa S; Iijima T
Hepatogastroenterology; 2004; 51(58):1144-7. PubMed ID: 15239263
[TBL] [Abstract][Full Text] [Related]
26. Gastric Metastasis of Hepatocellular Carcinoma With Gastrointestinal Bleeding After Liver Transplant: A Case Report.
Li L; Zhang WH; Meng FP; Ma XM; Shen LJ; Jin B; Li HW; Han J; Zhou GD; Liu SH
Transplant Proc; 2015 Oct; 47(8):2544-7. PubMed ID: 26518968
[TBL] [Abstract][Full Text] [Related]
27. Protein induced by vitamin K absence or antagonist II (PIVKA-II) producing large cell neuroendocrine carcinoma (LCNEC) of lung with multiple liver metastases: A case report.
Kurohama H; Mihara Y; Izumi Y; Kamata M; Nagashima S; Komori A; Matsuoka Y; Ueki N; Nakashima M; Ito M
Pathol Int; 2017 Feb; 67(2):105-109. PubMed ID: 28075042
[TBL] [Abstract][Full Text] [Related]
28. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
Aoyagi Y; Yanagi M; Asakura H
Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
[No Abstract] [Full Text] [Related]
29. [A Case of AFP and PIVKA- II Producing Gastric Cancer Presenting with Metachronous Multiple Liver Metastases].
Watanabe J; Kenjo A; Saze Z; Kimura T; Sato N; Osuka F; Endo H; Hanayama H; Tada T; Kikuchi T; Muto M; Kaneta A; Nishimagi A; Marubashi S; Gotoh M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1788-1790. PubMed ID: 28133132
[TBL] [Abstract][Full Text] [Related]
30. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia.
Miskad UA; Yano Y; Nakaji M; Kishi S; Itoh H; Kim SR; Ku Y; Kuroda Y; Hayashi Y
Pathol Int; 2001 Dec; 51(12):916-22. PubMed ID: 11844063
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
Yamanaka J; Yamanaka N; Nakasho K; Tanaka T; Ando T; Yasui C; Kuroda N; Takata M; Maeda S; Matsushita K; Uematsu K; Okamoto E
J Gastroenterol Hepatol; 2000 Oct; 15(10):1192-8. PubMed ID: 11106101
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic manifestations of metastatic hepatocellular carcinoma to the stomach: report of two cases.
Wang MH; Wu MS; Wang HP; Change YL; Lin JT
Gastrointest Endosc; 2000 Aug; 52(2):273-5. PubMed ID: 10922110
[No Abstract] [Full Text] [Related]
34. Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.
Poté N; Cauchy F; Albuquerque M; Cros J; Soubrane O; Bedossa P; Paradis V
Liver Int; 2018 Apr; 38(4):687-694. PubMed ID: 28872754
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma].
Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968
[TBL] [Abstract][Full Text] [Related]
36. Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
Morinaga S; Takahashi Y
Jpn J Clin Oncol; 1996 Aug; 26(4):258-63. PubMed ID: 8765186
[TBL] [Abstract][Full Text] [Related]
37. [A staining method of PIVKA-II by an indirect immunoenzyme technic].
Tanimoto K; Onji M; Nadano S; Kumon I; Michitaka K; Horiike N; Ohta Y
Rinsho Byori; 1989 Oct; 37(10):1139-42. PubMed ID: 2481050
[TBL] [Abstract][Full Text] [Related]
38. Gastric metastasis of hepatocellular carcinoma presenting as hematemesis.
Inagaki Y; Shiraki K; Takei Y
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):A16-7. PubMed ID: 23962547
[No Abstract] [Full Text] [Related]
39. [Carcinoma hepatoides of the stomach --case report and literature review].
Górnicka B; Ziarkiewicz-Wróblewska B; Muszyński J; Wróblewski T; Bogdańska M; Morton M; Wasiutyński A
Wiad Lek; 2003; 56(9-10):481-5. PubMed ID: 15049215
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
